Published in Inflammopharmacology on January 01, 1998
Mouse Models of Primary Sjogren's Syndrome. Curr Pharm Des (2015) 0.76
SJOEGREN'S SYNDROME. A CLINICAL, PATHOLOGICAL, AND SEROLOGICAL STUDY OF SIXTY-TWO CASES. Medicine (Baltimore) (1965) 7.46
Labial salivary gland biopsy in Sjögren's disease. J Clin Pathol (1968) 6.61
Increased risk of lymphoma in sicca syndrome. Ann Intern Med (1978) 4.63
THE DEVELOPMENT OF MALIGNANT LYMPHOMA IN THE COURSE OF SJOEGREN'S SYNDROME. Am J Med (1964) 4.07
Sjögren's syndrome (Sicca syndrome): current issues. Ann Intern Med (1980) 3.81
Self-reported breast implants and connective-tissue diseases in female health professionals. A retrospective cohort study. JAMA (1996) 3.69
A clinicopathologic study of Mikulicz's disease. Am J Pathol (1953) 3.17
Sjörgren's syndrome treated with bromhexine: a randomised clinical study. Br Med J (1978) 2.96
Labial salivary gland biopsy in Sjögren's syndrome. Assessment as a diagnostic criterion in 362 suspected cases. Arthritis Rheum (1984) 2.79
Sjögren's syndrome: autoimmune epithelitis. Clin Immunol Immunopathol (1994) 2.58
Benign lymphoepithelial lesion of the parotid gland adenolymphoma, chronic inflammation, lymphoepithelioma, lymphocytic tumor, Mikulicz disease. Cancer (1952) 2.50
Sjogren's syndrome. I. Sicca components. Q J Med (1973) 2.08
Liver disease in Sjögren's syndrome and rheumatoid arthritis. Lancet (1970) 2.00
Minor salivary gland involvement in Sjögren's syndrome. Oral Surg Oral Med Oral Pathol (1974) 1.99
A statistical aid to the diagnosis of keratoconjunctivitis sicca. Q J Med (1972) 1.81
A sicca syndrome in HIV infection: association with HLA-DR5 and CD8 lymphocytosis. Lancet (1989) 1.80
Differences in the clinical manifestations of sicca syndrome in the presence and absence of rheumatoid arthritis. Am J Med (1979) 1.79
Sjogren's syndrome. 2. Clinical associations and immunological phenomena. Q J Med (1973) 1.77
Reported complications of silicone gel breast implants: an epidemiologic review. Ann Intern Med (1996) 1.73
Advances in the diagnosis and concept of Sjögren's syndrome (autoimmune exocrinopathy). Bull Rheum Dis (1980) 1.64
A diffuse infiltrative CD8 lymphocytosis syndrome in human immunodeficiency virus (HIV) infection: a host immune response associated with HLA-DR5. Ann Intern Med (1990) 1.57
Correlation of goblet cell density and mucosal epithelial membrane mucin expression with rose bengal staining in patients with ocular irritation. Ophthalmology (1997) 1.54
Primary Sjögren's syndrome (SS) and malignant lymphoma. A retrospective cohort study of 55 patients with SS. Scand J Rheumatol (1995) 1.50
Rheumatoid arthritis complicated by infection with the human immunodeficiency virus and the development of Sjögren's syndrome. Arthritis Rheum (1989) 1.44
Salivary gland immunoglobulin and rheumatoid factor synthesis in Sjögren's syndrome. Natural history and response to treatment. Am J Med (1972) 1.32
Paraneoplastic autoimmune phenomena in patients with myelodysplastic syndromes: response to immunosuppressive therapy. Br J Haematol (1995) 1.31
Salivary mucins in oral mucosal defense. Gen Pharmacol (1996) 1.27
A clinical study of Sjogren's syndrome. Ann Intern Med (1963) 1.27
Mixed monoclonal cryoglobulinemia and monoclonal rheumatoid factor cross-reactive idiotypes as predictive factors for the development of lymphoma in primary Sjögren's syndrome. Arthritis Rheum (1996) 1.23
Expression of histocompatibility antigen HLA-DR by salivary gland epithelial cells in Sjögren's syndrome. Arthritis Rheum (1986) 1.22
Lymphocytic sialadenitis in the major and minor glands: a correlation in postmortem subjects. J Clin Pathol (1970) 1.19
Monocytoid B-cell lymphoma in patients with Sjögren's syndrome: a clinicopathologic study of 13 patients. Hum Pathol (1991) 1.17
T cell subpopulations in the labial minor salivary gland histopathologic lesion of Sjögren's syndrome. J Rheumatol (1991) 1.17
IgA and IgM rheumatoid factors in serum, saliva and other secretions: relationship to immunoglobulin ratios in systemic sicca syndrome and rheumatoid arthritis. Clin Exp Immunol (1983) 1.14
Lysozyme: President's Address. Proc R Soc Med (1932) 1.14
The prevalence of primary Sjögren's syndrome in a multiple sclerosis population. Ann Neurol (1989) 1.10
CD5-expressing B lymphocytes in the blood and salivary glands of patients with primary Sjögren's syndrome. J Autoimmun (1988) 1.03
The clinical picture of primary Sjögren's syndrome: a retrospective study. J Rheumatol (1983) 1.01
Autoantibody synthesis in salivary glands of Sjögren's syndrome patients. J Autoimmun (1989) 0.98
Sjögren's syndrome: historical overview and clinical spectrum of disease. Rheum Dis Clin North Am (1992) 0.97
Otolaryngological aspects of Sjögren's syndrome. Br Med J (1971) 0.97
Hepatitis C virus and Sjögren's syndrome. Arthritis Rheum (1993) 0.95
Sicca syndrome associated with hepatitis C virus infection. Arthritis Rheum (1996) 0.94
Low tear production in patients with diabetes mellitus is not due to Sjögren's syndrome. Clin Exp Rheumatol (1994) 0.92
Cytokine and adhesion molecule expression in the minor salivary glands of patients with Sjögren's syndrome and chronic sialoadenitis. Ann Rheum Dis (1995) 0.92
Autonomic neuropathy in systemic lupus erythematosus: cardiovascular autonomic function assessment. Ann Rheum Dis (1994) 0.92
Nodal and extranodal lymphoproliferative disorders in Sjogren's syndrome: a clinical and immunopathologic study. Hum Pathol (1990) 0.91
Immunologic, clinical, and pathologic aspects of human graft-versus-host disease. Mayo Clin Proc (1983) 0.91
Quantitative immunohistologic criteria are superior to the lymphocytic focus score criterion for the diagnosis of Sjögren's syndrome. Arthritis Rheum (1992) 0.87
Evidence that abnormalities of central neurohormonal systems are key to understanding fibromyalgia and chronic fatigue syndrome. Rheum Dis Clin North Am (1996) 0.86
Primary Sjögren's syndrome: a subjective description of the disease. Clin Exp Rheumatol (1990) 0.86
Vascular cell adhesion molecule 1 and alpha 4 and beta 1 integrins in lymphocyte aggregates in Sjögren's syndrome and rheumatoid arthritis. Ann Rheum Dis (1993) 0.86
Abnormal esophageal motility in primary Sjögren's syndrome. J Rheumatol (1976) 0.85
The autoimmune nature of aqueous tear deficiency. Ophthalmology (1986) 0.85
Sjögren's syndrome without mixed cryoglobulinemia is not associated with hepatitis C virus infection. Am J Gastroenterol (1994) 0.84
Epidemiology, pathogenesis, animal models, and treatment of Sjögren's syndrome. Curr Opin Rheumatol (1994) 0.84
Primary Sjögren's syndrome in men. Ann Rheum Dis (1995) 0.84
High frequency of t(14;18) translocation in salivary gland lymphomas from Sjögren's syndrome patients. J Exp Med (1991) 0.83
Sjögren's syndrome. Baillieres Clin Rheumatol (1995) 0.81
Primary Sjögren's syndrome and primary biliary cirrhosis: differences and similarities in the autoantibody profile. Clin Exp Rheumatol (1995) 0.79
Sjögren's syndrome in childhood. J Rheumatol (1995) 0.78
Quantification of plasma cells in labial salivary glands: increased expression of IgM in Sjögren's syndrome. J Oral Pathol Med (1990) 0.77
Studies of the viral flora in keratoconjunctivitis sicca. Br J Ophthalmol (1975) 0.75
Salivary mucous glycoprotein MG1 in Sjögren's syndrome. Clin Chim Acta (1997) 0.75
Sialectasis and HIV infection. Dentomaxillofac Radiol (1993) 0.75
Historical overview of Sjögren's syndrome. Clin Exp Rheumatol (1995) 0.75
Effects of chronic clonidine administration on parasympathetic-evoked rat saliva. Life Sci (1992) 0.75
Sjögren's syndrome. Rheum Dis Clin North Am (1992) 0.75
Sjögren's syndrome and hepatitis C virus infection. Clin Rheumatol (1995) 0.75
Anti-hepatitis C virus serology in primary Sjögren's syndrome: no evidence of cross-reactivity between rheumatoid factor and specific viral proteins. Clin Exp Rheumatol (1992) 0.75
Infectious parotitis in Sjögren's syndrome: a case report and review of the literature. J Rheumatol (1979) 0.75
A Clinical Type of Dysphagia. Proc R Soc Med (1919) 0.75
Sjogren's syndrome: its clinical manifestations and associations. S Afr Med J (1972) 0.75
Validation study of WOMAC: a health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee. J Rheumatol (1988) 35.68
Clinical studies with an articular index for the assessment of joint tenderness in patients with rheumatoid arthritis. Q J Med (1968) 27.34
Homoeopathic therapy in rheumatoid arthritis: evaluation by double-blind clinical therapeutic trial. Br J Clin Pharmacol (1980) 3.28
The MACTAR Patient Preference Disability Questionnaire--an individualized functional priority approach for assessing improvement in physical disability in clinical trials in rheumatoid arthritis. J Rheumatol (1987) 3.13
Occurrence of antibody to salivary duct epithelium in Sjogren's disease, rheumatoid arthritis, and other arthritides. A clinical and laboratory study. Ann Rheum Dis (1967) 2.43
Corticosteroid-induced suppression of the hypothalamo-pituitary-adrenal axis: observations on patients given oral corticosteroids for rheumatoid arthritis. Q J Med (1967) 2.38
Measurement of joint inflammation. A radioisotopic method. Ann Rheum Dis (1970) 2.35
Preference for endpoint measures in clinical trials: results of structured workshops. J Rheumatol (1983) 2.13
Sjogren's syndrome. I. Sicca components. Q J Med (1973) 2.08
Sjögren's syndrome and autoimmunity in a geriatric population. Age Ageing (1972) 2.01
Hypothesis: that rheumatoid arthritis will disappear. J Rheumatol (1979) 2.01
Judging "current disease activity" in rheumatoid arthritis--an international comparison. J Rheumatol (1983) 2.01
Liver disease in Sjögren's syndrome and rheumatoid arthritis. Lancet (1970) 2.00
Method for assessing therapeutic potential of anti-inflammatory antirheumatic drugs in rheumatoid arthritis. Br Med J (1973) 1.97
A statistical aid to the diagnosis of keratoconjunctivitis sicca. Q J Med (1972) 1.81
Measurement of clinical response to anti-inflammatory drug therapy in rheumatoid arthritis. Q J Med (1973) 1.80
Sjogren's syndrome. 2. Clinical associations and immunological phenomena. Q J Med (1973) 1.77
Gastric studies in sjögren's syndrome. Gut (1966) 1.73
A preliminary evaluation of the dimensionality and clinical importance of pain and disability in osteoarthritis of the hip and knee. Clin Rheumatol (1986) 1.70
Measurement of pain threshold in patients with rheumatoid arthritis, osteoarthritis, ankylosing spondylitis, and healthy controls. Clin Rheumatol (1989) 1.69
Episcleritis and scleritis. A study of their clinical manifestations and association with rheumatoid arthritis. Br J Ophthalmol (1976) 1.69
Liver disease in rheumatoid arthritis and Sjøgren's syndrome. Prospective study using biochemical and serological markers of hepatic dysfunction. Ann Rheum Dis (1975) 1.66
The articular scan in patients with rheumatoid arthritis: a possible method of quantitating joint inflammation using radio-technetium. Clin Sci (1968) 1.60
Salicylates and homoeopathy in rheumatoid arthritis: preliminary observations. Br J Clin Pharmacol (1978) 1.59
Derivation of knee joint synovial perfusion. Using the Xenon (133Xe) clearance technique. Ann Rheum Dis (1970) 1.59
Double blind randomized controlled trial of sodium meclofenamate (Meclomen) and diclofenac sodium (Voltaren): post validation reapplication of the WOMAC Osteoarthritis Index. J Rheumatol (1992) 1.53
HLA-D region genes and rheumatoid arthritis (RA): importance of DR and DQ genes in conferring susceptibility to RA. Ann Rheum Dis (1992) 1.52
Depression in rheumatoid arthritis. J R Coll Gen Pract (1977) 1.52
Radiological manifestations in 200 patients with ankylosing spondylitis: correlation with clinical features and HLA B27. J Rheumatol (1979) 1.52
Ibuprofen in rheumatoid arthritis. Clinical study of analgesic and anti-inflammatory activity. Ann Rheum Dis (1968) 1.47
Serum uric acid levels in normal pregnancy with observations on the renal excretion of urate in pregnancy. J Clin Pathol (1966) 1.43
Prior score availability: observations using the WOMAC osteoarthritis index. Br J Rheumatol (1991) 1.43
Evaluation of a functional index in rheumatoid arthritis. Scand J Rheumatol (1973) 1.42
A short review of the relationship between intestinal permeability and inflammatory joint disease. Clin Exp Rheumatol (1990) 1.42
Immunological responses in Sjogren's syndrome and rheumatoid arthritis. Clin Exp Immunol (1971) 1.41
Immunogenetics of polymyalgia rheumatica. Clin Exp Rheumatol (1994) 1.40
Serum sickness-like illness and leukocytoclastic vasculitis after intravenous streptokinase. J Am Acad Dermatol (1991) 1.40
Methotrexate in rheumatoid arthritis. Impact on quality of life assessed by traditional standard-item and individualized patient preference health status questionnaires. Arch Intern Med (1990) 1.40
Are gallstones less prevalent in rheumatoid arthritis? Clin Rheumatol (1991) 1.39
Is diet important in rheumatoid arthritis? Br J Rheumatol (1991) 1.39
Evidence based medicine: the median is not the message. J Rheumatol (2001) 1.38
Benefits of hospitalization in rheumatoid arthritis. Q J Med (1974) 1.37
Abnormalities in mineral metabolism suggestive of parathyroid over-activity in rheumatoid arthritis. Curr Med Res Opin (1975) 1.36
The McMaster Health Index Questionnaire as a measure of quality of life for patients with rheumatoid disease. J Rheumatol (1983) 1.35
Septic arthritis in patients with rheumatoid disease: a still underdiagnosed complication. J Rheumatol (1976) 1.31
Auranofin. Br J Rheumatol (1997) 1.30
Clinico-pharmacological studies and clinical evaluation of flurbiprofen. A new non-steroidal antirheumatic agent. Ann Rheum Dis (1972) 1.28
Rheumatoid arthritis antirheumatic drug trials. III. Setting the delta for clinical trials of antirheumatic drugs--results of a consensus development (Delphi) exercise. J Rheumatol (1991) 1.28
Genetic and non-genetic factors in simple goitre formation: evidence from a twin study. Q J Med (1967) 1.25
Generalised and localised bone loss in patients with rheumatoid arthritis. Scand J Rheumatol (1975) 1.21
Association of Thyrotoxicosis and Auto-immune Thyroiditis. Br Med J (1961) 1.20
How safe are anti-rheumatic drugs? A study of possible iatrogenic deaths in patients with rheumatoid arthritis. Health Bull (Edinb) (1975) 1.19
Distribution of certain autoantibodies in monozygotic and dizygotic twins. Ann Rheum Dis (1966) 1.17
Outcome measurement in osteoarthritis clinical trials: the case for standardisation. Clin Rheumatol (1984) 1.17
Observations on spontaneous improvement in patients with podagra: implications for therapeutic trials of non-steroidal anti-inflammatory drugs. Br J Clin Pharmacol (1987) 1.16
Poor quality of posts in clinical rheumatology: a cause of failure to advance the specialty. Br Med J (1976) 1.15
Radioisotope study of small joint inflammation in rheumatoid arthritis. Ann Rheum Dis (1971) 1.15
Controlled trial of clinical utility of serum salicylate monitoring in rheumatoid arthritis. J Rheumatol (1984) 1.15
Continued use of non-steroidal anti-inflammatory drugs: an index of clinical efficacy. Br J Clin Pharmacol (1978) 1.14
Penetration of sodium fusidate (Fucidin) in the synovial cavity. Scand J Rheumatol (1972) 1.13
Antirheumatic drugs: clinical pharmacology and therapeutic use. Drugs (1980) 1.12
Pulmonary involvement in systemic lupus erythematosus. Ann Rheum Dis (1978) 1.11
Isotope studies in normal and diseased knee joints: 99mTc uptake related to clinical assessment and to synovial perfusion measured by the 133Xe clearance technique. Clin Sci (1971) 1.10
Pulmonary infection and rheumatoid arthritis. Br J Dis Chest (1978) 1.10
Ankylosing spondylitis antirheumatic drug trials. III. Setting the delta for clinical trials of antirheumatic drugs--results of a consensus development (Delphi) exercise. J Rheumatol (1991) 1.10
A comparative study of signal versus aggregate methods of outcome measurement based on the WOMAC Osteoarthritis Index. Western Ontario and McMaster Universities Osteoarthritis Index. J Rheumatol (1994) 1.10
Serum uric acid in England and Scotland. Ann Rheum Dis (1977) 1.10
A comparative study of some commercially available tests for rheumatoid factor. J Clin Pathol (1974) 1.09
Relative roles of genetic and environmental factors in the control of serum uric acid levels in normouricaemic subjects. Ann Rheum Dis (1967) 1.08
NSAID and osteoarthritis--help or hindrance? J Rheumatol (1982) 1.07
Plasma immunoglobulin concentrations in twins. Clin Exp Immunol (1968) 1.07
Evaluation of analgesic action and efficacy of antirheumatic drugs. Study of 10 drugs in 684 patients with rheumatoid arthritis. J Rheumatol (1976) 1.06
Osteoarthritis: symptoms, signs and source of pain. Inflammopharmacology (2004) 1.06
Precipitating antibodies to cellular antigens in Sjögren's syndrome, rheumatoid arthritis, and other organ and nonorgan-specific autoimmune diseases. Ann Rheum Dis (1978) 1.05
Bone loss in patients with rheumatoid arthritis. Scand J Rheumatol (1975) 1.05
Observations on drug prescribing in rheumatoid arthritis. Br Med J (1974) 1.05
Ankylosing spondylitis antirheumatic drug trials. I. Effects of standardization procedures on observer dependent outcome measures. J Rheumatol (1991) 1.04
Rhythmic variations in pain, stiffness, and manual dexterity in hand osteoarthritis. Ann Rheum Dis (2002) 1.04
Indomethacin--aspirin interaction: a clinical appraisal. Br Med J (1975) 1.04
Corticosteroid-induced hypothalamo-pituitary-adrenal axis suppression. Prospective study using two regimens of corticosteroid therapy. Ann Rheum Dis (1968) 1.03
The detection of spinal pseudarthrosis in ankylosing spondylitis. Br J Radiol (1981) 1.01
Bone-resorbing activity in the sera of patients with rheumatoid arthritis. Clin Sci Mol Med (1976) 1.00
Circadian rhythm in pain, stiffness, and manual dexterity in rheumatoid arthritis: relation between discomfort and disability. Ann Rheum Dis (1991) 1.00
Personal points of view--the need for expansion of medical social work facilities and personnel in rheumatology. Health Bull (Edinb) (1974) 1.00
Clinical evaluation of two strategies for improving patient recall of prior drug therapy. Br J Clin Pharmacol (1984) 1.00
Indices of inflammatory activity. Relationship between isotope studies and clinical methods. Ann Rheum Dis (1970) 0.99
Inheritance of ankylosing spondylitis and HL-A antigen W27. Lancet (1974) 0.98
The economics of arthritis. Bull Rheum Dis (1973) 0.98
Methods of assessment used in ankylosing spondylitis clinical trials: a review. Br J Rheumatol (1991) 0.98
Interactions of anti-rheumatic drugs. Agents Actions Suppl (1977) 0.97
Antinuclear factors in synovial fluids. Lancet (1967) 0.97
Some clinical observations on the diurnal rhythm of plasma cortisol (11-OHCS) in patients with rheumatoid arthritis treated with oral corticosteroid drugs. Curr Med Res Opin (1974) 0.97
Ankylosing spondylitis antirheumatic drug trials. II. Tables for calculating sample size for clinical trials. J Rheumatol (1991) 0.97
The management of rheumatoid arthritis. Anglo Ger Med Rev (1968) 0.97
Otolaryngological aspects of Sjögren's syndrome. Br Med J (1971) 0.97
Reiter's syndrome re-evaluated. Scott Med J (1979) 0.96
Clinical trial of pentazocine in rheumatoid arthritis. Observations on the value of potent analgesics and placebos. Ann Rheum Dis (1973) 0.96
Nocturnal pain correlates with effusions in diseased hips. J Rheumatol (1992) 0.95
Pathogenic responses of bradykinin system in chronic inflammatory rheumatoid disease. Exp Toxicol Pathol (1994) 0.94